0
2020
Smart Insulin Or Glucose Responsive Insulin Market

Smart Insulin or Glucose Responsive Insulin Market

by Delivery Devices (Smart Insulin Pen and Smart Insulin Pump), Disease, (Type 1 Diabetes and Type 2 Diabetes), and Type (Rapid Acting, Intermediate Acting, Long Acting, Short Acting, and Premixed Type): Global Opportunity Analysis and Industry Forecast, 2019-2027

Report Code: A01349
Pages: 233
Aug 2020 | 11608 Views
Author(s) : Trupti W, Snehal M , Onkar S
Tables: 121
Charts: 43
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Smart Insulin Or Glucose Responsive Insulin Market

Request Now !

Smart Insulin or Glucose Responsive Insulin Market Overview:

The global smart insulin or glucose responsive insulin market size was valued at $2,773.73 million in 2019, and is expected to reach $6,174.30 million by 2027, registering a CAGR of 10.5% from 2020 to 2027. Smart insulin or glucose-responsive insulin is the next generation insulin that automatically responds to changing blood glucose levels. These products help in management of blood glucose level of diabetic patients in minimally invasive manner. Smart insulin works accordingly in response to blood glucose concentration i.e. higher the blood glucose higher is the concentration of insulin released and lower the blood glucose lower is the concentration of insulin released. It is a painless mode of introducing insulin compared to injectable insulin, reducing the risk of skin irritation caused due to needles.In addition, the dose volume is easily calculated in oral & inhalable insulin and helps to maintain the dosage time. The development of smart insulin is accelerating the growth of healthcare and digital science leading to cures and treatments of patients with Type 1 and Type 2 diabetes by advance upcoming approaches.

The market is expected to witness an exponential growth during the forecast period, owing to the benefits of using these advanced devices over conventional products and rise in healthcare expenditure. As per data published by the NCBI (National Center for Biotechnology Information) in 2016, six million people with diabetes used insulin either alone or in combination with an oral medication. Moreover, increase in disposable income among t diabetic patients and technological advancements of smart insulin products are anticipated to fuel the market growth.However, lack of awareness, cost restrains in developing regions, and less variability in products are expected to hinder the market growth. Development of affordable products with fewer side effects and presence of undiagnosed diabetic patients globally are expected to provide opportunities for the smart insulin or glucose responsive insulin market growth.

smart-insulin-or-glucose-responsive-insulin-Market-2020-2027

Global Smart Insulin Or Glucose Responsive Insulin Market Segmentation

The smart insulin or glucose responsive insulin market is segmented on the basis of type, disease, delivery devices, and region. By type, it is divided into rapid-acting, intermediate-acting, long-acting, short-acting and pre-mixed type. On the basis of disease, the market is bifurcated into Type 1 and Type 2 diabetes. On the basis of delivery devices, the smart insulin or glucose responsive insulin market is classified into smart insulin pen and smart insulin pump. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Smart Insulin or Glucose Responsive Insulin Market
By Delivery Device

Your browser does not support the canvas element.

Smart Insulin Pumps segment is projected as one of the most lucrative segment.

Get more information on this report : Request Sample Pages

Delivery Device segment review

By delivery devices, the smart insulin pumps segment accounted for 96% of the total market share in 2019, and is expected to exhibit a prominent growth rate in the future, owing to its increased adoption across the globe for diabetes. In addition, smart insulin pumps release small doses of insulin continuously, meanwhile patients can adjust the amount of insulin to be released pre and post mealtime by configuring the pump.

Smart Insulin or Glucose Responsive Insulin Market
By Disease

Your browser does not support the canvas element.

Type 1 diabetes segment holds a dominant position in 2019 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

Disease Type Segment Review

By disease type, type 2 diabetes cases are much more than type 1 diabetes. Most of the products used in the market areeither used for both types of diabetes or only for type 2. Type 2 diabetes is the most important contributor toward the market growth. Moreover, as patients suffering from type 2 diabetes are increasing at a higher rate, it is anticipated to be the fastest growing segment during the forecast period.

Smart Insulin or Glucose Responsive Insulin Market
By Type

Your browser does not support the canvas element.

Rapid acting insulin type segment is projected as one of the most lucrative segment.

Get more information on this report : Request Sample Pages

Type Segment Review

By type, the rapid acting segment is anticipated to grow at a significant rate during the forecast period. Rapid-acting insulin is one of the fastest acting insulins that start working in 15 minutes of its introduction in the body. The activity of this insulin is supposed to last for 5 hours. Some of the rapid-acting insulin available in the market are Humalog, Flaps and Novo Rapid, and Apia. Rapid-acting insulin are usually preferred in pumps that deliver little amounts of insulin into the body every few minutes.

Smart Insulin or Glucose Responsive Insulin Market
By Region

2027
North America 
Europe
Asia-Pacific
LAMEA

North America holds a dominant position in 2019 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

Region Segment Review

North America accounted for the majority of the smart insulin or glucose responsive insulin market share in 2019, and is anticipated to continue this trend during the forecast period. North America holds a dominant share in the global smart insulin or glucose responsive insulin market, owing to well-developed supply-side infrastructure, rapid acceptance of innovative technologies, and adequate reimbursements (as compared to other regions).

Comprehensive competitive analysis and profiles of major smart insulin or glucose responsive insulin market players such as CeQur, Diamesco Co, Eli lily and Company, Insulet Corporation, Medtronic Plc, Novo Nordisk A/S, F. Hoffmann-La Roche AG, Sanofi and Zealand Pharma are provided in this report.

Key Benefits For Stakeholders

  • Thereport entails a detailed quantitative analysis along with the global smart insulin or glucose responsive insulin market trends from 2019 to 2027 to identify the prevailing opportunities along with the strategic assessment.
  • The market trends are studied from 2019 to 2027.
  • The smart insulin or glucose responsive insulin market size and estimations are based on a comprehensive analysis of key developments in the industry.
  • An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves. 
  • The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market.

Key Market Segments

By Delivery Devices

  • Smart Insulin Pen
  • Smart Insulin Pump
  • Tethered Insulin Pumps
  • Insulin Patch Pumps

By Disease

  • Type 1 Diabetes
  • Type 2 Diabetes

By Type

  • Rapid Acting
  • Intermediate Acting
  • Long Acting
  • Short Acting
  • Premixed Type

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
 

Loading Table Of Content...


 
 

The digital diabetes management market is expected to witness a significant growth, owing to growing usage of healthcare applications by the patients and ever-increasing patient pool suffering from diabetes.

The key factor responsible for the growth of the smart insulin or glucose responsive insulin market is advancements in digital applications for monitoring blood glucose level with the help of augmented & virtual reality for diabetes management. These are painless mode of insulin delivery and reduce the risk of skin irritation caused due to needles. They are expected to replace injectable insulin, owing to their ease of using with improved efficiency. Furthermore, these smart insulin help to improve the adherence to medication, thus providing better diabetes management. The advancement in smart insulin or glucose responsive insulin along with improved effectiveness and usability will help to increase the adoption rate of these products, which will largely contribute towards the market growth. In addition, the rise in disposable income, favorable reimbursement policies, and increase in healthcare expenditure, will help to boost the market growth.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com
 
FREQUENTLY ASKED QUESTIONS?

A. The total market value of smart insulin or glucose responsive insulin market is $6,174.3 milion

A. The forecast period in the report si from 2020 to 2027

A. The market value of smart insulin or glucose responsive insulin market in 2019 was $2,773.73 million

A. Yes, smart insulin or glucose responsive insulin companies are profiled in the report

A. The top companies that hold the market share in smart insulin or glucose responsive insulin market are Eli lily and Company, Insulet Corporation, Medtronic, Novo Nordisk A/S, Roche, Sanofi

A. The top 5 emerging investments markets in the smart insulin or glucose responsive insulin market are Germany, Canada, France, China and UK

A. The key trends in the smart insulin or glucose responsive insulin market are surge in incidences of diabetes, rise in healthcare expenditure, and increased adoption of technologically advanced products

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Free Sample
RELATED TAGS

Purchase Full Report of
Smart Insulin Or Glucose Responsive Insulin Market

Start reading instantly.
This Report and over 19,935+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,456
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
    (Aug 2021 - Aug 2022)
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Aug 2021 - Aug 2022)
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Aug 2021 - Aug 2022)
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Aug 2021 - Aug 2022)
  • Enterprise
    License/PDF

  • $10,995
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Aug 2021 - Aug 2022)
  • Library
    Membership

  • $900 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers